Ng E Y, Trucksis M, Hooper D C
Infectious Disease Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114-2696.
Antimicrob Agents Chemother. 1994 Jun;38(6):1345-55. doi: 10.1128/AAC.38.6.1345.
We identified a quinolone resistance locus, flqB, linked to transposon insertion omega 1108 and fus on the SmaI D fragment of the Staphylococcus aureus NCTC 8325 chromosome, the same fragment that contains the norA gene. S. aureus norA cloned from flqB and flqB+ strains in Escherichia coli differed only in a single nucleotide in the putative promoter region. There was no detectable change in the number of copies of norA on the chromosomes of flqB strains, but they had increased levels of norA transcripts. Cloned norA produced resistance to norfloxacin and other hydrophilic quinolones and reduced norfloxacin accumulation in intact cells that was energy dependent, suggesting active drug efflux as the mechanism of resistance. Drug efflux was studied by measurement of norfloxacin uptake into everted inner membrane vesicles prepared from norA-containing E. coli cells. Vesicles exhibited norfloxacin uptake after the addition of lactate or NADH, and this uptake was abolished by carbonyl cyanide m-chlorophenylhydrazone and nigericin but not valinomycin, indicating that it was linked to the pH gradient across the cell membrane. Norfloxacin uptake into vesicles was also saturable, with an apparent Km of 6 microM, a concentration between those that inhibit the growth of flqB and flqB+ S. aureus cells, indicating that drug uptake is mediated by a carrier with a high apparent affinity for norfloxacin. Ciprofloxacin and ofloxacin competitively inhibited norfloxacin uptake into vesicles. Reserpine, which inhibits the multidrug efflux mediated by the bmr gene of bacillus subtilis, which is similar to norA, abolished norfloxacin uptake into vesicles as well as the norfloxacin resistance of an flqB mutant, suggesting a potential means for circumventing quinolone resistance as a result of drug efflux in S. aureus. These findings indicate that the chromosomal flqB resistance locus is associated with increased levels of expression of norA and strongly suggest that the NorA protein itself functions as a drug transporter that is coupled to the proton gradient across the cell membrane.
我们在金黄色葡萄球菌NCTC 8325染色体的SmaI D片段上鉴定出一个与转座子插入ω1108和fus相关的喹诺酮抗性位点flqB,该片段与包含norA基因的片段相同。从大肠杆菌中的flqB和flqB +菌株克隆的金黄色葡萄球菌norA仅在推定的启动子区域的一个核苷酸上有所不同。flqB菌株染色体上norA的拷贝数没有可检测到的变化,但它们的norA转录本水平有所增加。克隆的norA对诺氟沙星和其他亲水性喹诺酮产生抗性,并减少了完整细胞中诺氟沙星的积累,这是能量依赖性的,表明主动药物外排是抗性机制。通过测量诺氟沙星摄取到由含norA的大肠杆菌细胞制备的外翻内膜囊泡中来研究药物外排。添加乳酸或NADH后,囊泡表现出诺氟沙星摄取,并且这种摄取被羰基氰化物间氯苯腙和尼日利亚菌素消除,但缬氨霉素没有消除,表明它与跨细胞膜的pH梯度有关。诺氟沙星摄取到囊泡中也是可饱和的,表观Km为6 microM,该浓度介于抑制flqB和flqB +金黄色葡萄球菌细胞生长的浓度之间,表明药物摄取是由对诺氟沙星具有高表观亲和力的载体介导的。环丙沙星和氧氟沙星竞争性抑制诺氟沙星摄取到囊泡中。利血平抑制由枯草芽孢杆菌的bmr基因介导的多药外排,该基因与norA相似,消除了诺氟沙星摄取到囊泡中以及flqB突变体的诺氟沙星抗性,表明这是一种潜在的方法,可以规避金黄色葡萄球菌中由于药物外排导致的喹诺酮抗性。这些发现表明,染色体flqB抗性位点与norA表达水平的增加有关,并强烈表明NorA蛋白本身作为一种药物转运蛋白发挥作用,该转运蛋白与跨细胞膜的质子梯度偶联。